SV Life Sciences has closed its fourth fund with $572 million in capital commitments. The firm focuses on venture capital opportunities in the life sciences space, and had originally targeted $500 million. www.svlsla.com
SV Life Sciences Closes Fund IV
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.